Clinical Trials Logo

Heart Diseases clinical trials

View clinical trials related to Heart Diseases.

Filter by:

NCT ID: NCT04682977 Completed - Clinical trials for Uncontrolled Diabetes (HBA1c = 10)

Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline

Start date: April 22, 2021
Phase: N/A
Study type: Interventional

Conduct a pilot randomized control to assess the preliminary efficacy of IPROACTIF, an occupational therapist-delivered primary care intervention for aging and chronic disease management.

NCT ID: NCT04672538 Completed - Anesthesia Clinical Trials

Fontan Physiology Ventilation Strategy

Start date: March 2, 2021
Phase: N/A
Study type: Interventional

This study will investigate the different tidal volume (Vt) strategies during a cardiac catheterization procedure to determine whether or not low or high Vt have an impact on cardiac output. Research question: While maintaining the same minute ventilation/PaCO2, does higher Vt (10 cc/kg)/lower rate vs. lower Vt (6 cc/kg)/higher rate (maintaining consistent PEEP) result in improved cardiac output?

NCT ID: NCT04666857 Completed - Clinical trials for Congenital Heart Disease in Children

Family Centred Early Intervention of Infants With Congenital Heart Disease

Start date: May 31, 2021
Phase: N/A
Study type: Interventional

In this study the investigators aim to test the feasibility for therapists and acceptability to parents of an early motor intervention for infants with congenital heart disease (CHD) after open heart surgery. This intervention will be compared to the standard care of treatment that is recommended for infants with congenital heart disease at the University Children Hospital Zurich.

NCT ID: NCT04661657 Completed - Covid19 Clinical Trials

COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry

Start date: December 28, 2020
Phase:
Study type: Observational [Patient Registry]

COLUMBIA CARDS is a pilot study to understand how COVID-19 affects the heart. It is known that COVID-19 can affect the heart in different ways. COLUMBIA CARDS is studying why some COVID-19 survivors develop clinical conditions such as heart inflammation, fluid buildup, blood clots, and other cardiac problems during or after their COVID-19 illness, and why other ones do not. In this study, we will use cardiovascular magnetic resonance (CMR) and transthoracic echocardiography (TTE) to better understand the impact of COVID-19 on the heart.

NCT ID: NCT04657705 Completed - Heart Diseases Clinical Trials

Application of High Power Radio Frequency Energy in the Ventricular Tachycardia Treatment

Start date: December 5, 2020
Phase: N/A
Study type: Interventional

Background: Patient's freedom from VT after RFA remains non-optimal and it depends on many factors. One of them is the effective reduction of the myocardium with RF energy during the operation. The standardization of the parameters of RF will help to increase the success of the procedure. Hypothesis: Radiofrequency ablation of ventricular tachycardias with high power parameters has comparable safety and leads to greater efficacy (absence of ventricular tachycardias and all types of cardioverter-defibrillator therapies) in the long-term compared with ablation with standard parameters in patients with structural heart disease. Purpose: to evaluate the safety and the efficiency of ablation of ventricular tachycardia in patients with structural heart disease using high power RF energy.

NCT ID: NCT04650009 Completed - Clinical trials for Hypertrophic Cardiomyopathy

Physical Activity in Children With Inherited Cardiac Diseases

Start date: May 1, 2020
Phase:
Study type: Observational

Use lay language. Current guidelines regarding physical activity in patients with inherited arrhythmia and cardiomyopathy are mostly dedicated to adult patients, with a special focus on sports competition. Their application to the pediatric population has been scarcely evaluated. Physical activity is well known for its health benefits but may be dangerous in this population, which leads to confusion within the medical community and among patients. Actual physical activity of children with such inherited cardiac disorders is unknown. This study aimed to assess the level of physical activity in children with inherited arrhythmia and cardiomyopathy, and the adherence to the current European guidelines on the subject. Secondary objectives aimed to assess through a qualitative analysis the impact of the disease on physical activity and daily life in this population. The level of physical activity and adherence to current guidelines will be determined from interviews between the patient and the principal investigator. Each patient will be questioned in order to explore the experiences, motivations and feelings of participants regarding physical activity. The standardized questionnaire was created by the principal investigator and members of the clinical research team. The investigators believe that many children practice physical activity outside the current guidelines and hope to identify the main determinants of physical activity in this population.

NCT ID: NCT04645173 Completed - Cardiac Disease Clinical Trials

Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation

HEAL
Start date: February 2, 2021
Phase:
Study type: Observational

The objective of this study is to gather information on participants returning at time of CIED change-out or revision who underwent a device implantation with either a CanGaroo® envelope, TYRX™ envelope, or no envelope.

NCT ID: NCT04641169 Completed - Heart Diseases Clinical Trials

Concordance AUTOFEVG

CONCORDANCEVEF
Start date: June 8, 2021
Phase: N/A
Study type: Interventional

Clinical ultrasound has become essential in emergency medicine. The guidelines are to use of echocardiography in specific contexts: dyspnea, hypotension or chest pain. The evaluation of left ventricle ejection fraction (LVEF) is one of the basic objectives of echocardiography. The reference assessment in emergency medicine is visual assessment. It suffers from poor inter-observer reproducibility. Pocket ultrasound scanners seem to meet the constraints of point-of-care ultrasound. A new tool is available on a pocket ultrasound device: the automatic evaluation of LVEF. Its interest could be to have a better inter-observer reproducibility than visual evaluation.

NCT ID: NCT04635371 Completed - Clinical trials for Acute Cardiac Failure

Monitoring Patients With Acute Cardiac Disease Using a Wireless, Wearable, Non-invasive Monitor

Start date: November 20, 2020
Phase:
Study type: Observational

A prospective observational study in patients admitted with an acute cardiac disease, in which the PPG-based device will be attached to them on admission, for frequent monitoring of their vitals during hospitalization and interventional procedures. in parallel to currently-used and approved devices. Data will be crossed with gathered clinical and laboratory data, to study the device's ability to detect acute hemodynamic and respiratory changes during hospitalization, and gathering workflow information from the nursing staff.

NCT ID: NCT04635293 Completed - Cardiac Surgery Clinical Trials

Preoperative Infusion of Levosimendan in Patients Undergoing Cardiac Surgery

Start date: January 1, 2012
Phase: N/A
Study type: Interventional

The aim of this retrospective study will be to investigate the effect of the preoperative administration of levosimendan on the outcome of patients with compromised cardiac function undergoing cardiac surgery